Cargando…
A case series analysis on the clinical experience of Impella 5.5® at a large tertiary care centre
AIMS: We aimed to detail the early clinical experience with pVAD 5.5 at a large academic medical centre. Impella® 5.5 (Abiomed) is a temporary peripherally inserted left ventricular assist device (pVAD) used for the treatment of cardiogenic shock (CS). This system has several modifications aimed at...
Autores principales: | Kennel, Peter J., Lumish, Heidi, Kaku, Yuji, Fried, Justin, Kirtane, Ajay J., Karmpaliotis, Dimitri, Takayama, Hiroo, Naka, Yoshifumi, Sayer, Gabriel, Uriel, Nir, Takeda, Koji, Masoumi, Amirali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497328/ https://www.ncbi.nlm.nih.gov/pubmed/34402210 http://dx.doi.org/10.1002/ehf2.13512 |
Ejemplares similares
-
Comparison of Risk Models in the Prediction of 30-Day Mortality in Acute Myocardial Infarction–Associated Cardiogenic Shock
por: Ranard, Lauren S., et al.
Publicado: (2022) -
Single center experience and early outcomes of Impella 5.5
por: Funamoto, Masaki, et al.
Publicado: (2023) -
Aortic Valve Leaflet Disruption: A Severe Complication of Impella 5.5
por: Ghannam, Alexander D, et al.
Publicado: (2021) -
Successful extended use of Impella 5.5 as a bridge to heart transplantation
por: Sharaf, Omar M, et al.
Publicado: (2023) -
Prospective Comparison of a Percutaneous Ventricular Assist Device and Venoarterial Extracorporeal Membrane Oxygenation for Patients With Cardiogenic Shock Following Acute Myocardial Infarction
por: Garan, A. Reshad, et al.
Publicado: (2019)